Thalassemia: Pathophysiology, Diagnosis, and Advances in Treatment
Thalassemia Reports · 15.10.2024 · 14 (4) · 81-102
DOI: 10.3390/thalassrep14040010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thalassemia Reports, online erschienen am 15.10.2024. Verfasst von Idris Zubairu Sadiq und 7 weiteren Autor:innen. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Thalassemia represents a diverse group of inherited hematological disorders characterized by defective globin chain synthesis, leading to chronic anemia and associated complications. The complicated pathophysiology of beta-thalassemia involves genetic mutations or rarely deletions of the beta-globin gene on chromosome 11 whereas alpha-thalassemia involves deletions in the HBA1 and HBA2 genes or occasionally alterations to the DNA sequence in or around these genes. These mutation and deletion effects disrupt the balance of α/β-globin chain production, resulting in ineffective erythropoiesis, hemolysis, and a cascade of clinical manifestations including anemia, bone deformities, and iron overload. Advances in diagnostic techniques have enhanced our ability to detect and characterize these mutations, facilitating early and accurate diagnoses. Current management strategies encompass regular blood transfusions, the use of hydroxyurea to improve hemoglobin levels, and iron chelation therapy to prevent iron-related organ damage. Moreover, other therapeutics such as thalidomide for those not responding to hydroxyurea, Sirolimus for patients with immunodeficiencies, and use of vitamin E as an antioxidant have proven to be effective. Innovative therapies such as gene therapy and bone marrow transplantation offer promising curative potential, opening a new era in the treatment of thalassemia. This review focuses on pathophysiological mechanisms underlying thalassemia, explores the diagnostic methodologies, and highlights recent advancements in therapeutic approaches.
Zitieren
APA
Sadiq, I. Z., Abubakar, F. S., Usman, H. S., Abdullahi, A. D., Ibrahim, B., Kastayal, B. S., Ibrahim, M., & Hassan, H. A. (2024). Thalassemia: Pathophysiology, Diagnosis, and Advances in Treatment. Thalassemia Reports, 14(4), 81-102. https://doi.org/10.3390/thalassrep14040010
Vancouver
Sadiq IZ, Abubakar FS, Usman HS, Abdullahi AD, Ibrahim B, Kastayal BS, et al. Thalassemia: Pathophysiology, Diagnosis, and Advances in Treatment. Thalassemia Reports. 2024;14(4):81-102. doi:10.3390/thalassrep14040010
BibTeX
@article{Sadiq2024,
author = {Sadiq, Idris Zubairu and Abubakar, Fatima Sadiq and Usman, Hauwa Salisu and Abdullahi, Aliyu Dantani and Ibrahim, Bashiru and Kastayal, Babangida Sanusi and Ibrahim, Maryam and Hassan, Hassan Aliyu},
title = {Thalassemia: Pathophysiology, Diagnosis, and Advances in Treatment},
journal = {Thalassemia Reports},
year = {2024},
volume = {14},
number = {4},
pages = {81--102},
doi = {10.3390/thalassrep14040010}
}
EUVIMED